| ID |
PMID |
Sequence |
Chirality |
Peptide name |
Origin |
Family |
Nature |
Sub-cellular localization |
N terminal modification |
C terminal modification |
Uptake efficiency |
Uptake mechanism |
Cancer cell lines |
Patent number |
|
| 1142 | 21319732 | KMDCRWRWKCCKK | L | Crot (27-39) | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (78% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1143 | 21319732 | MDCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (83% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1144 | 21319732 | DCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (47% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1145 | 21319732 | CRWRWKCCKK | L | CyLoP-1 | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (greater than Tat, penetratin and R8) | Receptor mediated endocytic process | NIH-3T3, CCL-11, C6 glioma cells and PANC-1 | US20110027300 |
|
| 1146 | 21319732 | RWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (37% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1147 | 21319732 | KMDCRWRWKCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (79% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1148 | 21319732 | KMDCRWRWKKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1149 | 21319732 | KMDRWRWKKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (2% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1150 | 21319732 | KDCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (26% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1151 | 21319732 | KCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (39% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1152 | 21319732 | KRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1153 | 21319732 | MDCRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (48% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1154 | 21319732 | DCRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (43% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1155 | 21319732 | DCRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (23%of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1156 | 21319732 | CRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (50% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1157 | 21319732 | CRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (33% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1158 | 21319732 | RWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1159 | 21319732 | MDCRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (31% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1160 | 21319732 | DCRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (22% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1161 | 21319732 | CRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (34% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1162 | 21319732 | RWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (10% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1163 | 21319732 | CRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (54% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1164 | 21319732 | SRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (46% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1165 | 21319732 | SRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (14% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1166 | 21319732 | SRWRWKSCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (12% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1167 | 21319732 | CRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (10% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1168 | 21319732 | SRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (5% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1169 | 21319732 | CRFRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (66% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1170 | 21319732 | CRWRFKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (61% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1171 | 21319732 | CRFRFKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (63% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1172 | 21319732 | crwrwkcckk | D | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (52% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1173 | 21319732 | KCCKWRWRCK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (42% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1174 | 21319732 | kcckwrwrck | D | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (36% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1175 | 21319732 | CrWRWKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (38% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1176 | 21319732 | CRwRWKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1177 | 21319732 | CRWrWKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (32% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1178 | 21319732 | CRWRwKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (35% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1179 | 21319732 | CrwrwKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (37% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1180 | 21319732 | CRWRWKCGCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (59% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1181 | 21319732 | KCGCRWRWKCGCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (75% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1182 | 21319732 | CRWRWKCG | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (47% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1183 | 21319732 | KMDXRWRWKCCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (48% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1184 | 21319732 | KMDXRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (18% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1185 | 21319732 | KMDXRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (4% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1186 | 21319732 | KMDXRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (70% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1187 | 21319732 | MDCRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (38% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1188 | 21319732 | KMDCRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (58% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1189 | 21319732 | KMDCRWRWKSCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (29% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1190 | 21319732 | KMDSRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (24% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1191 | 21319732 | KMDCRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (15% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1192 | 21319732 | KMDSRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (12% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1193 | 21319732 | KMDSRWRWKSCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (21% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1194 | 21319732 | KMDSRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (31% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1195 | 21319732 | KMDCRWRPKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (31% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1196 | 21319732 | KMDCRPRPKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (9% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1197 | 21319732 | KMDXRPRPKCCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (6% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1198 | 21319732 | KMDXRPRPKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (5% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1199 | 21319732 | KMDXRPRPKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (6% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1200 | 21319732 | KMDCRPRPKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (7% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1201 | 21319732 | KMDCRPRPKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (9% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |